SGTX
Vanguard Group’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-23,144
| Closed | -$521K | – | 4638 |
|
|
2023
Q2 | $521K | Sell |
23,144
-277,768
| -92% | -$6.25M | ﹤0.01% | 4112 |
|
|
2023
Q1 | $280K | Hold |
300,912
| – | – | ﹤0.01% | 4268 |
|
|
2022
Q4 | $105K | Hold |
300,912
| – | – | ﹤0.01% | 4386 |
|
|
2022
Q3 | $152K | Buy |
300,912
+54,770
| +22% | +$27.7K | ﹤0.01% | 4456 |
|
|
2022
Q2 | $204K | Sell |
246,142
-64,360
| -21% | -$53.3K | ﹤0.01% | 4467 |
|
|
2022
Q1 | $456K | Sell |
310,502
-219,057
| -41% | -$322K | ﹤0.01% | 4419 |
|
|
2021
Q4 | $1.46M | Buy |
529,559
+126,376
| +31% | +$349K | ﹤0.01% | 4151 |
|
|
2021
Q3 | $2.28M | Buy |
403,183
+45,376
| +13% | +$256K | ﹤0.01% | 4022 |
|
|
2021
Q2 | $3.84M | Sell |
357,807
-10,930
| -3% | -$117K | ﹤0.01% | 3727 |
|
|
2021
Q1 | $8.24M | Buy |
368,737
+333,737
| +954% | +$7.46M | ﹤0.01% | 3258 |
|
|
2020
Q4 | $1.68M | Buy |
+35,000
| New | +$1.68M | ﹤0.01% | 3707 |
|